[Accepted, unedited version] The dark side of drug repurposing, from clinical trial challenges to antimicrobial resistance: analysis based on three major fields

• Egile Nagusiak: Iyad Y. Natsheh (Egilea), Majd M. Alsaleh (Egilea), Ahmad K. Alkhawaldeh (Egilea), Duaa K. Albadawi (Egilea), Maisa' M. Darwish (Egilea), Mohammed Jamal A. Shammout (Egilea)
• Formatua: Liburua
• Argitaratua: AboutScience Srl, 2024-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Drug repurposing is a strategic endeavor that entails the identification of novel therapeutic applications for pharmaceuticals that are already available in the market. Despite the advantageous nature of implement- ing this particular strategy owing to its cost-effectiveness and efficiency in reduci...